Should you chase the rally in PAVmed stock after it quadrupled on Wednesday?

Core Insights - PAVmed Inc's shares experienced a significant increase, more than quadrupling, following a major contract secured by its subsidiary, Lucid Diagnostics, from the US government [1] Company Summary - PAVmed Inc is a publicly traded company on NASDAQ under the ticker symbol PAVM [1] - The company's subsidiary, Lucid Diagnostics, has successfully obtained a substantial contract from the US government, which has positively impacted PAVmed's stock performance [1]